Results 211 to 220 of about 114,251,227 (259)

Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine

open access: yesVaccine, 2012
Adults 40 years of age and older have been shown to be hypo-responsive immunologically to the currently available hepatitis B virus (HBV) vaccines. Three intramuscular doses of a Toll-like receptor 9 agonist, 1018 immunostimulatory sequence (1018 ISS ...
Mong Cho, Sang Hoon Ahn, Dong Joon Kim
exaly   +1 more source

Hepatitis A vaccine uptake among men who have sex with men from a time-limited vaccination programme in Melbourne in 2018

Sexually Transmitted Infections, 2019
Objectives In 2017, an outbreak of hepatitis A among gay, bisexual and other men who have sex with men (MSM) was reported in Victoria, Australia. In 2018, the Victorian government implemented a free hepatitis A vaccination programme targeting all ...
Sam Burrell   +6 more
semanticscholar   +1 more source

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

The Lancet
BACKGROUND Hepatitis E virus (HEV) is a frequently overlooked causative agent of acute hepatitis. Evaluating the long-term durability of hepatitis E vaccine efficacy holds crucial importance.
Shou-Jie Huang   +27 more
semanticscholar   +1 more source

Long-term immunogenicity of single dose of live attenuated hepatitis A vaccine in Indian children

Indian Pediatrics, 2015
S. Bhave   +4 more
semanticscholar   +1 more source

Hepatitis A vaccine

Reactions weekly, 2016
M. Ceyhan
semanticscholar   +1 more source

Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality

Journal of Hepatology, 2021
Gerardo Nardone   +2 more
exaly  

Cost-Effectiveness Analyses of Hepatitis A Vaccine

PharmacoEconomics (Auckland), 2012
A. Anonychuk   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy